Last reviewed · How we verify
Baofeikang Granule
At a glance
| Generic name | Baofeikang Granule |
|---|---|
| Also known as | Treatment Group |
| Sponsor | Beijing Municipal Science & Technology Commission |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- A Clinical Evaluation of Baofeikang Granule in Combined Pulmonary Fibrosis and Emphysema Treatment (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Baofeikang Granule CI brief — competitive landscape report
- Baofeikang Granule updates RSS · CI watch RSS
- Beijing Municipal Science & Technology Commission portfolio CI